This company has been marked as potentially delisted and may not be actively trading. NASDAQ:CSII Cardiovascular Systems (CSII) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Cardiovascular Systems Stock (NASDAQ:CSII) 30 days 90 days 365 days Advanced Chart Get Cardiovascular Systems alerts:Sign Up Key Stats Today's Range$20.00▼$20.0050-Day Range$19.87▼$20.0052-Week Range$12.26▼$20.57Volume4,300 shsAverage Volume765,906 shsMarket Capitalization$843.96 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewCardiovascular Systems, Inc. is a medical device company, which engages in the development and commercialization of solutions for treating vascular and coronary disease. It offers orbital atherectomy systems for both peripheral and coronary commercial applications. The company was founded in 1989 and is headquartered in St. Paul, MN.Read More… Receive CSII Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cardiovascular Systems and its competitors with MarketBeat's FREE daily newsletter. Email Address CSII Stock News HeadlinesResearch shows how trained immunity links to cardiovascular diseaseNovember 8, 2024 | msn.comLarge-scale genetic study identifies targets that could reduce cardiovascular risk by modulating blood metabolitesOctober 29, 2024 | msn.comMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.May 16, 2025 | American Alternative (Ad)Migraines linked to healthy vascular system despite cardiovascular risk factorsOctober 23, 2024 | msn.comCardiovascular scientists identify potential new treatment for failing heartsOctober 17, 2024 | msn.comRisk for Most Cardiovascular Events Reduced After COVID-19 VaccinationOctober 17, 2024 | msn.comStanding more may not reduce cardiovascular disease risk, could increase circulatory issuesOctober 17, 2024 | msn.comNew nanotherapy targets artery inflammation in cardiovascular diseaseOctober 11, 2024 | msn.comSee More Headlines CSII Stock Analysis - Frequently Asked Questions How were Cardiovascular Systems' earnings last quarter? Cardiovascular Systems, Inc. (NASDAQ:CSII) released its quarterly earnings results on Wednesday, February, 8th. The medical device company reported ($0.20) EPS for the quarter, missing analysts' consensus estimates of ($0.15) by $0.05. The firm's revenue was up 3.9% on a year-over-year basis. What other stocks do shareholders of Cardiovascular Systems own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cardiovascular Systems investors own include Meta Platforms (META), Netflix (NFLX), Advanced Micro Devices (AMD), Tesla (TSLA), JPMorgan Chase & Co. (JPM), NVIDIA (NVDA) and Home Depot (HD). Company Calendar Last Earnings2/08/2023Today5/16/2025Fiscal Year End6/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryHealth Care Equipment Current SymbolNASDAQ:CSII CIK1180145 Webwww.csi360.com Phone(651) 259-1600Fax612-677-3355Employees780Year Founded1989Profitability EPS (Most Recent Fiscal Year)($0.97) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-36,930,000.00 Net Margins-15.79% Pretax Margin-15.73% Return on Equity-15.39% Return on Assets-11.93% Debt Debt-to-Equity Ratio0.08 Current Ratio6.04 Quick Ratio4.92 Sales & Book Value Annual Sales$239.84 million Price / Sales3.52 Cash FlowN/A Price / Cash FlowN/A Book Value$6.12 per share Price / Book3.27Miscellaneous Outstanding Shares42,198,000Free Float40,594,000Market Cap$843.96 million OptionableOptionable Beta0.74 Social Links 7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.Get This Free Report This page (NASDAQ:CSII) was last updated on 5/16/2025 by MarketBeat.com Staff From Our PartnersMusk’s AI Masterplan – Our #1 AI Stock to Buy NowMusk has launched a bold new AI initiative—and while you can’t invest in it directly, one overlooked stock cou...Behind the Markets | Sponsored🚨 Nvidia Just Inked a $7B AI Deal—This Could Change EverythingOn Wednesday, Nvidia stock surged—again. Why? Because Saudi Arabia just announced a multi-billion-dollar AI...Timothy Sykes | SponsoredA New Wealth Divide Is Forming NowOver the years, my proprietary stock system has identified some of the biggest winners long before Wall Street...InvestorPlace | Sponsored How much money will YOU make when gold hits $5,000?What if I told you there was a way to secure a shot at making asymmetric gains from gold’s current historic bu...Eagle Publishing | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | SponsoredBitcoin Just Broke $100K – Are You Positioned?This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardiovascular Systems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardiovascular Systems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.